Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Nervana Elbakary"'
Autor:
Nervana Elbakary, Sami Ouanes, Sadaf Riaz, Oraib Abdallah, Islam Mahran, Noriya Al-Khuzaei, Yassin Eltorki
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Major Depressive Disorder (MDD) requires therapeutic interventions during the initial month after being diagnosed for better disease outcomes. International guidelines recommend a duration of 4–12 weeks for an initial antidepres
Externí odkaz:
https://doaj.org/article/d90a261a28ab43ce8ceb517ae6fe7cda
Autor:
Nervana Elbakary, Sadaf Riaz, Islam Mahran, Ahmed Hani Assar, Oraib Abdallah, Rania Abukuhail, Noriya AlKhuzaei, Yassin Eltorki
Publikováno v:
Heart and Mind, Vol 5, Iss 4, Pp 138-143 (2021)
Background: Countries launch vaccination programs to ensure vaccination coverage as part of the global health security. Special populations including patients with severe mental illness are under average vaccination rate. We aimed to improve the perc
Externí odkaz:
https://doaj.org/article/1d7e809338da4aa4b66f4ecba2371b20
Autor:
Sadaf Riaz, Sami Ouanes, Nervana Elbakary, Oraib Abdallah, Islam Mahran, Yassin Eltorki, Noriya Al-Khuzaei
Publikováno v:
BMC Psychiatry, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Psychiatry
BMC Psychiatry
Background Major Depressive Disorder (MDD) requires therapeutic interventions during the initial month after being diagnosed for better disease outcomes. International guidelines recommend a duration of 4–12 weeks for an initial antidepressant (IAD
Autor:
Sadaf Riaz, Yassin Eltorki, Nervana Elbakary, Noriya Al-Khuzaei, Ahmed Hani Assar, Islam Mahran, Rania Abukuhail, Oraib Abdallah
Publikováno v:
Heart and Mind, Vol 5, Iss 4, Pp 138-143 (2021)
Background: Countries launch vaccination programs to ensure vaccination coverage as part of the global health security. Special populations including patients with severe mental illness are under average vaccination rate. We aimed to improve the perc
Autor:
Chile. Clínica Alemana de Santiago. Santiago, Rayyan Abdulaziz Attya Fadel, Rand A. Alattar, Winnie Mathur, Murillo Macedo Lobo Filho, Nervana Elbakary, Fernanda Cruvinel de Abreu, Ronan Jose Vieira Neto, Maham Zahid, Fabiana Patricia Morosini Perez, Luis Jesús López Aboytes, Mohak Bariatrics, Laura A. Downey, Felix Hofmann, Gustavo Costa Baumgratz Lopes, Tristan Mirko Struja, Daniel Silva Nogueira, Thiago Artioli, Juan Sebastian Vargas Hernandez, Uruguay. Centro Hospitalario Pereira Rossell. Montevideo, Pablo Ignacio Carreno Montenegro, Daniela Goyes, Salma Elnour Mohamed, Jessica Monteiro Machado, Heba Jamaluddin Mominkhan, Ahmed K.J Elnajjar, Maria Julia Minetto, Nadeem Asghar Cheema, Atamai Caetano Moraes, Jael Garrido Dominguez, Roberta Rossi Grudtner, Colombia. Fundacíon Clínica Shaio. Bogota, Federico Javier Nunez Ricardo, Faissal Nemer Hajar, Cesar Caverzan
Publikováno v:
Principles and Practice of Clinical Research Journal. 6:6-12
Introduction: Anesthetic strategies to improve postoperative pain management after Total Knee Arthroplasty (TKA) include multimodal pain management to minimize opiate requirements. Postoperatively, subcutaneous standard bupivacaine HCl is often used.
Autor:
Sami Ouanes, Yassin Eltorki, Sadaf Riaz, Nervana Elbakary, Islam Mahran, Oraib Abdallah, Noriya Al-Khuzaei
Background: Major Depressive Disorder (MDD) requires therapeutic interventions during the initial month after being diagnosed for better disease outcomes. International guidelines recommend a duration of 4-12 weeks for an initial antidepressant (IAD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebe4da1d73424657361860223e46896b
https://doi.org/10.21203/rs.3.rs-120061/v1
https://doi.org/10.21203/rs.3.rs-120061/v1
Background: CANMAT 2018 guidelines identify two phases of Major depressive disorder (MDD) treatment: an acute phase (getting to symptomatic remission), and a maintenance phase (preventing relapse and recurrence). CANMAT recommends increasing the anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ea52248f35c498ee7f84ddabf78b309
https://doi.org/10.14293/s2199-1006.1.sor-.pp3asgl.v1
https://doi.org/10.14293/s2199-1006.1.sor-.pp3asgl.v1
Autor:
Nervana Elbakary, Hazem Hashem
Bakground: Gabapentin was approved by FDA for the treatment of epilepsy, and as an analgesic for post-herpetic neuralgia (PHN). Gabapentin has been prescribed off-label for a wide range of disorders. Off-label use of gabapentin has been estimated to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4271aa0130c803ecc673e14bc5f29336
https://doi.org/10.14293/s2199-1006.1.sor-.pprt3ds.v1
https://doi.org/10.14293/s2199-1006.1.sor-.pprt3ds.v1